Raymond James & Associates’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$3.2M Sell
14,250
-7,025
-33% -$1.26M ﹤0.01% 1933
2024
Q2
$3.04M Buy
21,275
+76
+0.4% +$11.7K ﹤0.01% 1914
2024
Q1
$3.32M Buy
21,199
+8,602
+68% +$1.39M ﹤0.01% 1849
2023
Q4
$2.27M Sell
12,597
-478
-4% -$86.5K ﹤0.01% 2028
2023
Q3
$2.35M Sell
13,075
-2,821
-18% -$558K ﹤0.01% 1919
2023
Q2
$2.83M Sell
15,896
-1,277
-7% -$294K ﹤0.01% 1848
2023
Q1
$3.7M Buy
17,173
+2,402
+16% +$576K ﹤0.01% 1669
2022
Q4
$3.25M Buy
14,771
+176
+1% +$32.3K ﹤0.01% 1700
2022
Q3
$1.97M Sell
14,595
-425
-3% -$73K ﹤0.01% 1964
2022
Q2
$2.43M Sell
15,020
-253
-2% -$39.5K ﹤0.01% 1873
2022
Q1
$2.88M Buy
15,273
+3,047
+25% +$648K ﹤0.01% 1880
2021
Q4
$3.31M Buy
12,226
+304
+3% +$103K ﹤0.01% 1823
2021
Q3
$4.33M Buy
11,922
+1,259
+12% +$412K ﹤0.01% 1592
2021
Q2
$3.66M Buy
10,663
+6,046
+131% +$2M ﹤0.01% 1709
2021
Q1
$1.61M Buy
4,617
+1,067
+30% +$353K ﹤0.01% 2169
2020
Q4
$917K Sell
3,550
-2,198
-38% -$605K ﹤0.01% 2408
2020
Q3
$1.65M Buy
5,748
+3,546
+161% +$833K ﹤0.01% 1878
2020
Q2
$415K Buy
+2,202
New +$358K ﹤0.01% 2720
2020
Q1
Sell
-1,692
Closed -$280K 3754
2019
Q4
$280K Buy
+1,692
New +$281K ﹤0.01% 3123
2019
Q1
Sell
-3,050
Closed -$428K 3730
2018
Q4
$428K Buy
3,050
+476
+18% +$63.1K ﹤0.01% 2640
2018
Q3
$443K Buy
+2,574
New +$433K ﹤0.01% 2793
2018
Q2
Sell
-1,529
Closed -$257K 3684
2018
Q1
$257K Buy
+1,529
New +$207K ﹤0.01% 2989

Other funds holding ONC